103 related articles for article (PubMed ID: 12196132)
1. Inhibition of toxicity and protofibril formation in the amyloid-beta peptide beta(25-35) using N-methylated derivatives.
Doig AJ; Hughes E; Burke RM; Su TJ; Heenan RK; Lu J
Biochem Soc Trans; 2002 Aug; 30(4):537-42. PubMed ID: 12196132
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.
Hughes E; Burke RM; Doig AJ
J Biol Chem; 2000 Aug; 275(33):25109-15. PubMed ID: 10825171
[TBL] [Abstract][Full Text] [Related]
3. N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure.
Kokkoni N; Stott K; Amijee H; Mason JM; Doig AJ
Biochemistry; 2006 Aug; 45(32):9906-18. PubMed ID: 16893191
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
Gordon DJ; Sciarretta KL; Meredith SC
Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
[TBL] [Abstract][Full Text] [Related]
5. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.
Pollack SJ; Sadler II; Hawtin SR; Tailor VJ; Shearman MS
Neurosci Lett; 1995 Jan; 184(2):113-6. PubMed ID: 7724043
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils.
Bodles AM; Guthrie DJ; Harriott P; Campbell P; Irvine GB
Eur J Biochem; 2000 Apr; 267(8):2186-94. PubMed ID: 10759841
[TBL] [Abstract][Full Text] [Related]
7. Retro-inversal of intracellular selected β-amyloid-interacting peptides: implications for a novel Alzheimer's disease treatment.
Acerra N; Kad NM; Griffith DA; Ott S; Crowther DC; Mason JM
Biochemistry; 2014 Apr; 53(13):2101-11. PubMed ID: 24601543
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of amyloid beta-protein aggregation mediated by GM1-containing raft-like membranes.
Matsuzaki K; Noguch T; Wakabayashi M; Ikeda K; Okada T; Ohashi Y; Hoshino M; Naiki H
Biochim Biophys Acta; 2007 Jan; 1768(1):122-30. PubMed ID: 17069749
[TBL] [Abstract][Full Text] [Related]
9. Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity.
Bodles AM; Guthrie DJ; Greer B; Irvine GB
J Neurochem; 2001 Jul; 78(2):384-95. PubMed ID: 11461974
[TBL] [Abstract][Full Text] [Related]
10. Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation.
Liu Y; Pukala TL; Musgrave IF; Williams DM; Dehle FC; Carver JA
Bioorg Med Chem Lett; 2013 Dec; 23(23):6336-40. PubMed ID: 24157371
[TBL] [Abstract][Full Text] [Related]
11. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide.
Howlett DR; Jennings KH; Lee DC; Clark MS; Brown F; Wetzel R; Wood SJ; Camilleri P; Roberts GW
Neurodegeneration; 1995 Mar; 4(1):23-32. PubMed ID: 7600183
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ
Alghazwi M; Smid S; Musgrave I; Zhang W
Neurochem Int; 2019 Mar; 124():215-224. PubMed ID: 30639263
[TBL] [Abstract][Full Text] [Related]
13. The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.
Seilheimer B; Bohrmann B; Bondolfi L; Müller F; Stüber D; Döbeli H
J Struct Biol; 1997 Jun; 119(1):59-71. PubMed ID: 9216088
[TBL] [Abstract][Full Text] [Related]
14. Congo red protects against toxicity of beta-amyloid peptides on rat hippocampal neurones.
Burgevin MC; Passat M; Daniel N; Capet M; Doble A
Neuroreport; 1994 Dec; 5(18):2429-32. PubMed ID: 7696573
[TBL] [Abstract][Full Text] [Related]
15. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
16. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
17. A strategy for designing inhibitors of beta-amyloid toxicity.
Ghanta J; Shen CL; Kiessling LL; Murphy RM
J Biol Chem; 1996 Nov; 271(47):29525-8. PubMed ID: 8939877
[TBL] [Abstract][Full Text] [Related]
18. Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-β.
Sugiki T; Utsunomiya-Tate N
Biochem Biophys Res Commun; 2013 Nov; 441(2):493-8. PubMed ID: 24383085
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
20. In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.
Walsh DM; Hartley DM; Condron MM; Selkoe DJ; Teplow DB
Biochem J; 2001 May; 355(Pt 3):869-77. PubMed ID: 11311152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
